According to Aurobindo Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.30456. At the end of 2023 the company had a P/S ratio of 2.29.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.29 | 122.2% |
2022 | 1.03 | -43.39% |
2021 | 1.82 | -18.52% |
2020 | 2.23 | 83.51% |
2019 | 1.22 | -47.75% |
2018 | 2.33 | -7.93% |
2017 | 2.53 | -0.75% |
2016 | 2.55 | -32.18% |
2015 | 3.76 | 31.74% |
2014 | 2.85 | 87.09% |
2013 | 1.52 | 52.72% |
2012 | 0.9980 |